Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.33 |
| ▸ | KDM5A | P29375 | 4/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | KDM4A | O75164 | 2/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9624015 | 0.92 | DNM1 (0.43) | ALDH1A1KDM4CKDM5ACES2CES1 | |
| SCHEMBL5253602 | 0.89 | CA12 (0.43) | ALDH1A1CA12CA1CA9MMP1 | |
| SCHEMBL9792595 | 0.86 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9846342 | 0.86 | ALDH1A1 (0.34) | ALDH1A1CA12CA9 | |
| SCHEMBL3314937 | 0.77 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL9065643 | 0.76 | ALDH1A1 (0.33) | ALDH1A1CA12CA1CA9MMP1 | |
| SCHEMBL9424278 | 0.75 | ALDH1A1 (0.46) | ALDH1A1CA12CA1CA9MMP1 | |
| Hexane SCHEMBL11414372 | 0.73 | ALDH1A1 (0.55) | ALDH1A1CES2CES1 | |
| SCHEMBL10388723 | 0.73 | CA1 (0.52) | ALDH1A1CA12CA1CA9MMP1 | |
| SCHEMBL3318245 | 0.72 | EPHX2 (0.40) | ALDH1A1CA12CA1CA9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8445622-B2 | Process for preparing polyisocyanates | BASF SE (DE) | 2013-05-21 | — | — | US | disclosed |
| US-20100292396-A1 | PROCESS FOR PREPARING POLYISOCYANATES | BASF SE (DE) | 2010-11-18 | — | — | US | disclosed |
| US-20100105833-A1 | WATER-EMULSIFIABLE POLYISOCYANATES | BASF SE (DE) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292396-A1 | PROCESS FOR PREPARING POLYISOCYANATES | PCBP1, ALKBH3, AGPS | ALDH1A1 2951/4885CA12 1000/4885CA1 1250/4885 |
| US-20100105833-A1 | WATER-EMULSIFIABLE POLYISOCYANATES | AQP3, AQP1, AQP4 | ALDH1A1 2387/4885CA12 1138/4885CA1 2442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.